Evaluation of ‘SAEFVIC’, A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia

Abstract

Introduction: Australia is traditionally an early adopter of vaccines, therefore comprehensive and effective post-licensure vaccine pharmacovigilance is critical to maintain confidence in immunisation, both nationally and internationally. With adverse event following immunisation (AEFI) surveillance the responsibility of Australian jurisdictions, Victoria operates an enhanced passive AEFI surveillance system integrated with clinical services, called ‘SAEFVIC’ (Surveillance of Adverse Events Following Vaccination In the Community). Objective: The aim of this study was to evaluate Victoria’s current AEFI surveillance system ‘SAEFVIC’ and inform ongoing quality improvement of vaccine pharmacovi..